These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23874843)

  • 1. Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.
    Matsumoto Y; Matsuura T; Aoyagi H; Matsuda M; Hmwe SS; Date T; Watanabe N; Watashi K; Suzuki R; Ichinose S; Wake K; Suzuki T; Miyamura T; Wakita T; Aizaki H
    PLoS One; 2013; 8(7):e68992. PubMed ID: 23874843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin as antiviral agent against Hepatitis C Virus.
    Ashfaq UA; Masoud MS; Nawaz Z; Riazuddin S
    J Transl Med; 2011 Jul; 9():112. PubMed ID: 21762538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro.
    Hang X; Peng H; Song H; Qi Z; Miao X; Xu W
    J Virol Methods; 2015 Sep; 222():150-7. PubMed ID: 26116793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
    Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
    Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.
    Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS
    Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple effects of silymarin on the hepatitis C virus lifecycle.
    Wagoner J; Negash A; Kane OJ; Martinez LE; Nahmias Y; Bourne N; Owen DM; Grove J; Brimacombe C; McKeating JA; Pécheur EI; Graf TN; Oberlies NH; Lohmann V; Cao F; Tavis JE; Polyak SJ
    Hepatology; 2010 Jun; 51(6):1912-21. PubMed ID: 20512985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizin inhibits influenza A virus uptake into the cell.
    Wolkerstorfer A; Kurz H; Bachhofner N; Szolar OH
    Antiviral Res; 2009 Aug; 83(2):171-8. PubMed ID: 19416738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
    Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
    Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
    Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
    Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
    Campos GRF; Bittar C; Jardim ACG; Shimizu JF; Batista MN; Paganini ER; Assis LR; Bartlett C; Harris M; Bolzani VDS; Regasini LO; Rahal P
    J Gen Virol; 2017 Jul; 98(7):1693-1701. PubMed ID: 28699869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
    Gao R; Gao W; Xu G; Xu J; Ren H
    World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.
    Cheng YL; Lan KH; Lee WP; Tseng SH; Hung LR; Lin HC; Lee FY; Lee SD; Lan KH
    Clin Sci (Lond); 2013 Nov; 125(9):439-48. PubMed ID: 23659500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
    Galani BR; Sahuc ME; Sass G; Njayou FN; Loscher C; Mkounga P; Deloison G; Brodin P; Rouillé Y; Tiegs G; Séron K; Moundipa PF
    Arch Virol; 2016 May; 161(5):1169-81. PubMed ID: 26843184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
    Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
    J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.
    Schaefer EA; Meixiong J; Mark C; Deik A; Motola DL; Fusco D; Yang A; Brisac C; Salloum S; Lin W; Clish CB; Peng LF; Chung RT
    World J Gastroenterol; 2016 Dec; 22(45):9954-9965. PubMed ID: 28018102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.